scholarly journals Cerebral Aneurysm Regrowth and Coil Unraveling After Incomplete Guglielmi Detachable Coil Embolization: Serial Angiographical and Histological Findings-Case Report-

2003 ◽  
Vol 43 (6) ◽  
pp. 293-297 ◽  
Author(s):  
Kentaro MORI ◽  
Yasuaki NAKAO ◽  
Naoaki HORINAKA ◽  
Ryo WADA ◽  
Akira HIRANO ◽  
...  
1997 ◽  
Vol 3 (2_suppl) ◽  
pp. 149-153 ◽  
Author(s):  
A. Hyodo ◽  
Y. Matsumaru ◽  
I. Anno ◽  
H. Sato ◽  
N. Kato ◽  
...  

Instead of the Guglielmi detachable coil (GDC; Target Therapeutics, Fremont, California), the interlocking detachable coil (IDC; Target Therapeutics, Fremont, California) was the only available detachable and retractable coil in Japan until February 1997. From October 1993 to February 1997, endovascular treatment with IDCs were attempted for 25 cases of cerebral aneurysm. Within 25 trials, 15 cases were treated by intra-aneurysmal coil embolization, 9 cases by parent artery or proximal occlusion using IDCs and one case could not be treated due to anatomical problems of the aneurysm. As for 15 cases of intra-aneurysmal coil packing, complete occlusion was performed in 9 cases, subtotal occlusion in 4 cases and partial occlusion in 2 cases. In one of the partial occluded cases, a coil compaction occurred 6 months after embolization. Distal emboli were recognized on CT after embolization in 3 cases, however, only one case was symptomatic. Intraoperative bleeding occurred in one case, but no obvious hemorrhage after coil embolization in any case. From our experiences, treatment for poor-grade ruptured aneurysm is still difficult, but intravascular surgery for cerebral aneurysms using IDC is possible and a useful alternative, especially for surgically difficult aneurysm.


2000 ◽  
Vol 6 (2) ◽  
pp. 141-145
Author(s):  
R. Guzman ◽  
L. Remonda ◽  
K.O. Lövblad ◽  
A. Barth ◽  
G. Schroth

We present the case of a patient with acute onset of headache who showed a flow-related acutely ruptured aneurysm on the feeding artery of an AVM in the angiogram. Rerupture of the aneurysm occurred during angiography after endovascular treatment with a Guglielmi detachable coil. The possible mechanisms leading to rupture of the aneurysm are discussed.


2001 ◽  
Vol 43 (10) ◽  
pp. 884-890 ◽  
Author(s):  
S. Matsubara ◽  
K. Satoh ◽  
J. Satomi ◽  
T. Miyamoto ◽  
M. Uno ◽  
...  

2013 ◽  
Vol 7 (1) ◽  
pp. 40-45 ◽  
Author(s):  
Tomoyuki YOSHIHARA ◽  
Fumitaka YAMANE ◽  
Ryuzaburo KANAZAWA ◽  
Shinya KOHYAMA ◽  
Ikuo OCHIAI ◽  
...  

2020 ◽  
Vol 7 (1) ◽  
pp. 35-38
Author(s):  
Masatoshi Takagaki ◽  
Tomoyoshi Nakagawa ◽  
Shuhei Kawabata ◽  
Nobuyuki Izutsu ◽  
Takeo Nishida ◽  
...  

Neurosurgery ◽  
2002 ◽  
Vol 50 (4) ◽  
pp. 899-902 ◽  
Author(s):  
Michael J. Alexander ◽  
Gary R. Duckwiler ◽  
Y. Pierre Gobin ◽  
Fernando Viñuela

Abstract OBJECTIVE AND IMPORTANCE: Thromboembolic complications after cerebral aneurysm treatment with Guglielmi detachable coils (Boston Scientific/Target, Fremont, CA) are not infrequent; in a University of California, Los Angeles institutional review of 720 treated aneurysms, thromboembolic complications occurred in 2.5% of cases. The development of intraluminal thrombus during the embolization procedure, however, may be diagnosed promptly and treated effectively with appropriate therapy. This report describes the use of intravenously administered abciximab for the treatment of intraprocedural arterial thrombus encountered during the coil embolization of a recently ruptured anterior communicating artery aneurysm. CLINICAL PRESENTATION: A 45-year-old man presented with severe headache 12 days before transfer to our institution. He had no neurological deficits at admission. Previous computed tomography of the brain demonstrated subarachnoid hemorrhage, and magnetic resonance angiography from the other institution demonstrated a 4-mm anterior communicating artery aneurysm. INTERVENTION: The patient underwent Guglielmi detachable coil embolization of the aneurysm under systemic heparinization. During the embolization, however, a thrombus developed in the proximal left A2 segment. The patient was given an intravenous infusion (20 mg) of abciximab for 10 minutes, and within 15 minutes dissolution of the thrombus was observed with no angiographic evidence of distal emboli. After reversal of general anesthesia, the patient exhibited minimal right leg weakness, which resolved within 1 hour. CONCLUSION: Abciximab may be a useful adjunct for endovascular treatment of patients with cerebral aneurysms in whom intraprocedural arterial thrombus is encountered.


Sign in / Sign up

Export Citation Format

Share Document